Compare DexCom, Inc. (DXCM) vs Reddit Inc (RDDT) Price & Performance

DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.

The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.

Reddit (RDDT) trades at $193.79, down 4.65% in the last session, with a bullish technical signal from moving averages. The company shows strong fundamentals with 91.37% gross margins and 28.6% net income margin, though valuation ratios remain elevated (P/E 56.58). Recent earnings beat expectations in two of the last three quarters, with Q2 2026 results due July 30, 2026.

Outlook remains positive with analyst consensus at Buy (63%) and $236.89 price target, representing 22% upside. Key risks include high valuation multiples and competitive digital advertising pressures. Revenue growth trajectory and AI safety initiatives position RDDT for sustained expansion if execution continues.